MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 12-16-2024
Enzo Biochem Long Term Debt Current 2011-2026 | ENZ
Annual Long Term Debt Current Enzo Biochem
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 841 K | 980 K | 896 K | 3.42 M | 4.12 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.12 M | 841 K | 2.05 M |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
824 K | $ 22.03 | 3.19 % | $ 99.4 M |  Israel |
 |
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M |  USA |
 |
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | USA |
 |
BioNano Genomics
BNGO
|
2.99 M | $ 1.6 | -0.62 % | $ 2.03 M | USA |
 |
Co-Diagnostics
CODX
|
838 K | $ 6.05 | 6.14 % | $ 178 M | USA |
 |
Castle Biosciences
CSTL
|
1.66 M | $ 40.8 | 1.83 % | $ 1.13 B | USA |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
 |
Danaher Corporation
DHR
|
173 M | $ 234.89 | -0.73 % | $ 172 B | USA |
 |
DarioHealth Corp.
DRIO
|
111 K | $ 12.11 | -10.18 % | $ 344 M | Israel |
 |
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M |  China |
 |
DexCom
DXCM
|
21.1 M | $ 70.15 | 0.37 % | $ 27.1 B | USA |
 |
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Exact Sciences Corporation
EXAS
|
27.4 M | $ 101.62 | -0.03 % | $ 18.8 B | USA |
 |
CareDx, Inc
CDNA
|
5.94 M | $ 18.99 | 0.96 % | $ 1.02 B | USA |
 |
Fulgent Genetics
FLGT
|
1.44 M | $ 27.97 | 7.62 % | $ 846 M | USA |
 |
Celcuity
CELC
|
172 K | $ 109.72 | 4.47 % | $ 4.33 B | USA |
 |
Anixa Biosciences
ANIX
|
29 K | $ 3.26 | 2.4 % | $ 104 K | USA |
 |
Guardant Health
GH
|
29.2 M | $ 110.12 | -1.97 % | $ 13.5 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
241 M | $ 29.05 | 1.22 % | $ 20 B |  Niderland |
 |
Aspira Women's Health
AWH
|
77 K | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
99 M | $ 244.09 | 1.5 % | $ 44.3 B | USA |
 |
Illumina
ILMN
|
79 M | $ 151.07 | 2.65 % | $ 24 B | USA |
 |
Charles River Laboratories International
CRL
|
54.2 M | $ 216.28 | - | $ 11.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
173 M | $ 178.22 | -1.22 % | $ 19.8 B | USA |
|
Biodesix
BDSX
|
719 K | $ 5.86 | -2.82 % | $ 760 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
185 M | $ 253.83 | -2.49 % | $ 21.3 B | USA |
 |
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
24.3 M | $ 202.64 | 0.58 % | $ 16.7 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
21.5 M | $ 710.27 | 0.49 % | $ 58.6 B | USA |
 |
Lantheus Holdings
LNTH
|
1.87 M | $ 69.22 | -0.66 % | $ 4.79 B | USA |
 |
Biomerica
BMRA
|
358 K | $ 2.78 | 5.41 % | $ 6.39 M | USA |
 |
Bioventus
BVS
|
4.06 M | $ 7.56 | -1.18 % | $ 474 M | USA |
 |
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | Israel |
 |
QIAGEN N.V.
QGEN
|
23.4 M | $ 47.23 | 0.32 % | $ 10.5 B | Niderland |
 |
Mettler-Toledo International
MTD
|
29.8 M | $ 1 462.87 | -1.54 % | $ 31 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
12.8 M | $ 6.7 | 2.68 % | $ 607 M | USA |
 |
ENDRA Life Sciences
NDRA
|
96.9 K | $ 4.51 | -1.96 % | $ 2.42 M | USA |
 |
NeoGenomics
NEO
|
3.38 M | $ 12.69 | -0.78 % | $ 1.61 B | USA |